---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-017864"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2022-06-27T23:59:59+00:00"
generated_at: "2026-06-24T23:09:19.241497+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Oncotelic issues $335K convertible note to Blue Lake Partners as part of $1M financing

## Summary
- Issued $335,000 convertible promissory note to Blue Lake Partners, LLC at 12% interest.
- Note matures in one year; convertible into common stock at $0.10 per share.
- Issued 3,025,000 warrants to purchase common stock at $0.20 per share.
- Financing part of cumulative $1M raise via JH Darbie; $605K from Mast Hill in May 2022.
- Proceeds for general working capital; not for insider loans or illegal purposes.

## SEC filing metadata
- accession: 0001493152-22-017864
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2022-06-27T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315222017864/0001493152-22-017864-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315222017864/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-017864
- JSON: https://secwatch.observer/filing/0001493152-22-017864.json
- Plain text: https://secwatch.observer/filing/0001493152-22-017864.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.